ESRP2 and hepatocellular carcinoma: Consistently, HCC specimens with ESRP2 silencing showed higher methylation density compared to non‐tumor tissues (Figure 1G), supporting that promoter hypermethylation might be the major cause of ESRP2 downregulation in HCC.